Home›Stock Screener›Lupin›Quarterly Results

Lupin Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹1,469 Cr
QMar 2026
Quarterly Results

In Mar 2026, Lupin (LUPIN) reported revenue ₹7,533 Cr and net profit ₹1,469 Cr — revenue +34.1% YoY. Analyse LUPIN shareholder distribution to track promoter, FII and institutional holdings.

LUPIN Quarterly Results — Revenue, Profit & EPS Highlights

Lupin latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Lupin share price chart.

  • Revenue of ₹7,533 Cr in Mar 2026 (-9.8% vs Jun 2026, +34.1% vs Mar 2025)
  • Net Profit of ₹1,469 Cr in Mar 2026 (+3.7% vs Jun 2026, +87.9% vs Mar 2025)
  • EBITDA of ₹2,412 Cr in Mar 2026 (-4.3% vs Jun 2026)
  • Operating Margin of 31.0% in Mar 2026 (+2.0pp vs Jun 2026)
  • Earnings Per Share of ₹34.83 in Mar 2026 (+12.5% vs Jun 2026)

Lupin Quarterly Results — Revenue, EBITDA, Net Profit & EPS

LUPIN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 7,533 8,348 6,921 5,619 6,243 -9.8% 34.1%
Net Profit (₹ Cr) 1,469 1,417 1,485 782 1,222 - -
EBITDA (₹ Cr) 2,412 2,520 2,215 1,273 1,702 - -
EPS (₹) 34.83 30.95 32.36 16.93 26.70 - -
Operating Margin (%) 31.0% 29.0% 31.0% 22.0% 26.0% - -

LUPIN Share Price Trend — 1-Year Movement Across Quarterly Results

Lupin 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View LUPIN 52-week performance for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 19.5%
EBITDA Margin 32.0%
Operating Margin 31.0%
ROE (Annual) 26.1%

Balance Sheet Highlights

Total Assets ₹38,365 Cr
Total Equity ₹22,513 Cr
Current Assets ₹24,027 Cr
Current Liabilities ₹3,200 Cr

Cash Flow Analysis

Operating Cash Flow ₹7,335 Cr
Investing Cash Flow ₹-3,865 Cr
Financing Cash Flow ₹-846 Cr
Net Cash Flow ₹2,624 Cr

Current Market Data

Current Price ₹2083.00
Exchange NSE
Last Updated Sep 18, 2026

Revenue Trend (₹ Cr)

Mar 2025 5,619
Sept 2025 6,921
Jun 2026 8,348
Mar 2026 7,533

Net Profit Trend (₹ Cr)

Mar 2025 782
Sept 2025 1,485
Jun 2026 1,417
Mar 2026 1,469

Operating Margin Trend (%)

Mar 2025 22.0%
Sept 2025 31.0%
Jun 2026 29.0%
Mar 2026 31.0%

LUPIN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Lupin latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Cipla
Mar 2026 		₹112,654.03 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores